The quantification of blood-brain barrier disruption using dynamic contrast-enhanced magnetic resonance imaging in aging rhesus monkeys with spontaneous type 2 diabetes mellitus

Microvascular lesions of the body are one of the most serious complications that can affect patients with type 2 diabetes mellitus. The blood-brain barrier (BBB) is a highly selective permeable barrier around the microvessels of the brain. This study investigated BBB disruption in diabetic rhesus monkeys using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). Multi-slice DCE-MRI was used to quantify BBB permeability. Five diabetic monkeys and six control monkeys underwent magnetic resonance brain imaging in 3 Tesla MRI system. Regions of the frontal cortex, the temporal cortex, the basal ganglia, the thalamus, and the hippocampus in the two groups were selected as regions of interest to calculate the value of the transport coefficient Ktrans using the extended Tofts model. Permeability in the diabetic monkeys was significantly increased as compared with permeability in the normal control monkeys. Histopathologically, zonula occludens protein-1 decreased, immunoglobulin G leaked out of the blood, and nuclear factor E2-related factor translocated from the cytoplasm to the nuclei. It is likely that diabetes contributed to the increased BBB permeability.

[1]  Thomas Hambrock,et al.  Assessment of prostate cancer aggressiveness using dynamic contrast-enhanced magnetic resonance imaging at 3 T. , 2013, European urology.

[2]  Walter H. Backes,et al.  Blood–brain barrier impairment in dementia: Current and future in vivo assessments , 2015, Neuroscience & Biobehavioral Reviews.

[3]  Hartwig Wolburg,et al.  The disturbed blood-brain barrier in human glioblastoma. , 2012, Molecular aspects of medicine.

[4]  Axel Montagne,et al.  Optimal acquisition and modeling parameters for accurate assessment of low Ktrans blood–brain barrier permeability using dynamic contrast‐enhanced MRI , 2016, Magnetic resonance in medicine.

[5]  Thierry Metens,et al.  Quantitative DCE-MRI for prediction of pathological complete response following neoadjuvant treatment for locally advanced breast cancer: the impact of breast cancer subtypes on the diagnostic accuracy , 2016, European Radiology.

[6]  Chun-Jung Juan,et al.  Effects of Microvascular Permeability Changes on Contrast-Enhanced T1 and Pharmacokinetic MR Imagings After Ischemia , 2013, Stroke.

[7]  Saeid Taheri,et al.  Quantitative measurement of blood‐brain barrier permeability in human using dynamic contrast‐enhanced MRI with fast T1 mapping , 2011, Magnetic resonance in medicine.

[8]  E. Vonken,et al.  Influence of partial volume on venous output and arterial input function. , 2006, AJNR. American journal of neuroradiology.

[9]  H. Larsson,et al.  Accurate Determination of Blood–Brain Barrier Permeability Using Dynamic Contrast-Enhanced T1-Weighted MRI: A Simulation and in vivo Study on Healthy Subjects and Multiple Sclerosis Patients , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[10]  Joseph A. Frank,et al.  Differential microstructure and physiology of brain and bone metastases in a rat breast cancer model by diffusion and dynamic contrast enhanced MRI , 2011, Clinical & Experimental Metastasis.

[11]  Leif Østergaard,et al.  Analysis of partial volume effects on arterial input functions using gradient echo: A simulation study , 2009, Magnetic resonance in medicine.

[12]  B. Hansen,et al.  Investigation and treatment of type 2 diabetes in nonhuman primates. , 2012, Methods in molecular biology.

[13]  Jette L. Frederiksen,et al.  Permeability of the blood–brain barrier predicts conversion from optic neuritis to multiple sclerosis , 2015, Brain : a journal of neurology.

[14]  B. T. Hawkins,et al.  Increased blood–brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases , 2006, Diabetologia.

[15]  A. Jackson,et al.  Experimentally‐derived functional form for a population‐averaged high‐temporal‐resolution arterial input function for dynamic contrast‐enhanced MRI , 2006, Magnetic resonance in medicine.

[16]  Yin-Cheng Huang,et al.  The adult neural stem cell niche: lessons for future neural cell replacement strategies. , 2007, Neurosurgery clinics of North America.

[17]  I. Herman,et al.  The pericyte: cellular regulator of microvascular blood flow. , 2009, Microvascular research.

[18]  Geoffrey J M Parker,et al.  Comparison of model‐based arterial input functions for dynamic contrast‐enhanced MRI in tumor bearing rats , 2009, Magnetic resonance in medicine.

[19]  Laurent Hermoye,et al.  Inflow correction of hepatic perfusion measurements using T1‐weighted, fast gradient‐echo, contrast‐enhanced MRI , 2004, Magnetic resonance in medicine.

[20]  Anthony Dohan,et al.  Diabetic Microangiopathy: Impact of Impaired Cerebral Vasoreactivity and Delayed Angiogenesis After Permanent Middle Cerebral Artery Occlusion on Stroke Damage and Cerebral Repair in Mice , 2014, Diabetes.

[21]  Carles Arús,et al.  A new ex vivo method to evaluate the performance of candidate MRI contrast agents: a proof-of-concept study , 2014, Journal of Nanobiotechnology.

[22]  Sonia Grego,et al.  Three-dimensional culture conditions differentially affect astrocyte modulation of brain endothelial barrier function in response to transforming growth factor β1 , 2015, Brain Research.

[23]  D. Rujescu,et al.  Higher glucose levels associated with lower memory and reduced hippocampal microstructure , 2013, Neurology.

[24]  Arne Klungland,et al.  Glial-conditional deletion of aquaporin-4 (Aqp4) reduces blood–brain water uptake and confers barrier function on perivascular astrocyte endfeet , 2011, Proceedings of the National Academy of Sciences.

[25]  O Henriksen,et al.  Quantitation of blood‐brain barrier defect by magnetic resonance imaging and gadolinium‐DTPA in patients with multiple sclerosis and brain tumors , 1990, Magnetic resonance in medicine.

[26]  Victor Mor-Avi,et al.  Myocardial perfusion: near-automated evaluation from contrast-enhanced MR images obtained at rest and during vasodilator stress. , 2012, Radiology.

[27]  Paul K Crane,et al.  Different patterns of cerebral injury in dementia with or without diabetes. , 2009, Archives of neurology.

[28]  Hartwig Wolburg,et al.  Tight junctions of the blood-brain barrier: development, composition and regulation. , 2002, Vascular pharmacology.

[29]  Joanna M. Wardlaw,et al.  Tracer kinetic modelling for DCE-MRI quantification of subtle blood–brain barrier permeability , 2016, NeuroImage.

[30]  David J. Begley,et al.  Structure and function of the blood–brain barrier , 2010, Neurobiology of Disease.

[31]  Yang Yang,et al.  Comparison of the Clinical Manifestations of Type 2 Diabetes Mellitus Between Rhesus Monkey (Macaca mulatta lasiotis) and Human Being , 2013, Pancreas.

[32]  Jeremy Seto,et al.  Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease. , 2012, The Journal of clinical investigation.

[33]  G. Rosenberg,et al.  Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. , 2011, Stroke.

[34]  Eleni Sakka,et al.  Blood pressure and sodium: Association with MRI markers in cerebral small vessel disease , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[35]  Karen J. Ferguson,et al.  Willis on narcolepsy , 2003, Journal of neurology, neurosurgery, and psychiatry.

[36]  E. Rostrup,et al.  Measurement of brain perfusion, blood volume, and blood‐brain barrier permeability, using dynamic contrast‐enhanced T1‐weighted MRI at 3 tesla , 2009, Magnetic resonance in medicine.

[37]  José Luís Alves,et al.  Blood–brain barrier and traumatic brain injury , 2014, Journal of neuroscience research.

[38]  Arthur W. Toga,et al.  Blood-Brain Barrier Breakdown in the Aging Human Hippocampus , 2015, Neuron.

[39]  C. Iadecola,et al.  Dangerous Leaks: Blood-Brain Barrier Woes in the Aging Hippocampus , 2015, Neuron.

[40]  E. Rostrup,et al.  Abnormal blood–brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI☆☆☆ , 2013, NeuroImage: Clinical.

[41]  Lippincott Williams Wilkins,et al.  Higher glucose levels associated with lower memory and reduced hippocampal microstructure , 2014, Neurology.

[42]  Steven P Sourbron,et al.  Classic models for dynamic contrast‐enhanced MRI , 2013, NMR in biomedicine.

[43]  R. Ransohoff,et al.  Development, maintenance and disruption of the blood-brain barrier , 2013, Nature Medicine.

[44]  Christian Hölscher,et al.  Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease. , 2011, Biochemical Society transactions.

[45]  B. Hansen,et al.  Nuclear magnetic resonance-determined lipoprotein abnormalities in nonhuman primates with the metabolic syndrome and type 2 diabetes mellitus. , 2007, Metabolism: clinical and experimental.

[46]  Maximilian Reiser,et al.  Quantification of cerebral blood flow, cerebral blood volume, and blood–brain‐barrier leakage with DCE‐MRI , 2009, Magnetic resonance in medicine.

[47]  Joanna M. Wardlaw,et al.  Assessment of blood–brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review , 2014, NeuroImage: Clinical.

[48]  Timothy Q. Duong,et al.  A Quantitative MRI Method for Imaging Blood-Brain Barrier Leakage in Experimental Traumatic Brain Injury , 2014, PloS one.

[49]  Anant Madabhushi,et al.  Identifying in vivo DCE MRI markers associated with microvessel architecture and gleason grades of prostate cancer , 2016, Journal of magnetic resonance imaging : JMRI.

[50]  Hassan Bagher-Ebadian,et al.  Model selection in measures of vascular parameters using dynamic contrast‐enhanced MRI: experimental and clinical applications , 2013, NMR in biomedicine.

[51]  B. Winblad,et al.  Diabetes, Alzheimer disease, and vascular dementia , 2010, Neurology.

[52]  J. Szmydynger-Chodobska,et al.  Blood–Brain Barrier Pathophysiology in Traumatic Brain Injury , 2011, Translational Stroke Research.

[53]  Y. Yasutomi,et al.  Diabetes Mellitus Accelerates Aβ Pathology in Brain Accompanied by Enhanced GAβ Generation in Nonhuman Primates , 2015, PLoS ONE.

[54]  Yao-Sheng Tung,et al.  A quantitative pressure and microbubble‐size dependence study of focused ultrasound‐induced blood‐brain barrier opening reversibility in vivo using MRI , 2012, Magnetic resonance in medicine.

[55]  Kylie Kavanagh,et al.  Old world nonhuman primate models of type 2 diabetes mellitus. , 2006, ILAR journal.

[56]  Roland Bammer,et al.  Magnetic Resonance Imaging Profile of Blood–Brain Barrier Injury in Patients With Acute Intracerebral Hemorrhage , 2013, Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.